SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Procyon Biopharma Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tim Cruise who wrote (144)8/13/1999 8:45:00 AM
From: Ian@SI  Read Replies (1) of 356
 
Tim,

No, I won't mark my daytimer.

To bring a new treatment through to NDA takes large 10s of Millions to small 100s of millions.

Procyon won't do this without a treatment that has at least passed Phase 1 trials, has a partner with deep pockets, and a disease for which there currently is no alternative that leads to a satisfactory outcome.

Wanting a company to succeed is often much different than the prerequisite conditions for success.

I'll hold my QLT for a very long time unless its story changes.

Good luck trading Procyon.

Ian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News